Large Granular Lymphocyte Leukemia - 3 Studies Found

Active, not recruiting : Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
:
  • Adult B Acute Lymphoblastic Leukemia
  • Adult T Acute Lymphoblastic Leukemia
  • Drug: Alisertib Given PO
RECRUITING : Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
: T-Cell Large Granular Lymphocyte Leukemia
: 2024-11-21
: Given PO
RECRUITING : Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
: Large Granular Lymphocyte Leukemia
: 2024-11-21
: Siltuximab will be given on day 1 of each cycle.The dose will be 11 mg/kg given over 1 hour by intravenous infusion.Each cycle is thr